London Calling 2024 - Speakers
Speakers
Check out the line up of speaking at London Calling 2024.
A
:quality(80))
Dr. Ahmad Abou TayounAl Jalila Children’s Specialty Hospital & Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, UAE
:quality(80))
Antoni P.A. HendrickxNational Institute for Public Health and the Environment, Netherlands
:quality(80))
Andre HolzerHolzer Scientific Consultancy, Germany
:quality(80))
Anoushka JoglekarNew York Genome Center, USA
:quality(80))
Adrien LegerDirector, Modified Base Research, Oxford Nanopore Technologies
:quality(80))
Alex ShawImperial College London, UK
:quality(80))
Alex TrotterDevelopment Scientist – Translational Development, Oxford Nanopore Technologies
:quality(80))
Alexander WittenbergKeyGene, Netherlands
:quality(80))
Akelia Wauchope-OdumboAssociate Director, Technical Applications — Americas, Oxford Nanopore Technologies
B
:quality(80))
Bryant CatanoSenior Product Support Scientist, Oxford Nanopore Technologies
:quality(80))
Prof. Benjamin KippMayo Clinic, USA
:quality(80))
Bosheng LiInstitute of Advanced Agricultural Sciences, Peking University, China
:quality(80))
Ben PriceNatural History Museum, UK
C
:quality(80))
Claire AndersonUniversity College London, UK
:quality(80))
Chris AlderBioinformatician, Oxford Nanopore Technologies
:quality(80))
Clive BrownChief Technology, Innovation, and Product Officer, Oxford Nanopore Technologies
:quality(80))
Chao Chun LiuSimon Fraser University, Canada
:quality(80))
Dr. Charles K. CooperbioMérieux, France
:quality(80))
Dr. Clemens JakobiLonza, Switzerland
:quality(80))
Dr. Carolyn TregidgoVP, Late Stage and Applied Product Development, Oxford Nanopore Technologies
D
:quality(80))
Daniel BrantonHarvard University, USA
:quality(80))
David W. DeamerUniversity of California, Santa Cruz, USA
Dan FordhamDirector, Strategic Product Management EMEA, Oxford Nanopore Technologies
Dongdong LuInstitute of Advanced Agricultural Sciences, Peking University, China
:quality(80))
Dr. Danny E. MillerUniversity of Washington, USA
:quality(80))
Devin OglesbeeMayo Clinic, USA
E
:quality(80))
Prof. Emma BapleUniversity of Exeter and South West NHS Genomics Laboratory Hub, UK
:quality(80))
Ethan Hill‘Iolani School, USA
:quality(80))
Emma WhiteVP, Marketing Operations, Oxford Nanopore Technologies
:quality(80))
Eddy de BoerUniversity Medical Center Groningen, Netherlands
:quality(80))
H
:quality(80))
Dr. Helen Bulbeckbrainstrust, UK
:quality(80))
Hagan BayleyUniversity of Oxford, UK
:quality(80))
Dr. Helen GunterBASE mRNA Facility, The University of Queensland, Australia
:quality(80))
Hanlee JiStanford University, USA
:quality(80))
Heather Ritchie-ParkerRoyal Zoological Society of Scotland, UK
I
:quality(80))
Prof. Ian AbbsGuy’s and St Thomas’ NHS Foundation Trust, UK
:quality(80))
Dr. Inès HassanTony Blair Institute for Global Change, UK
J
:quality(80))
Jessica AndersonSenior Field Applications Scientist, Oxford Nanopore Technologies
:quality(80))
Jean-Francois BrepsonPathoQuest, France
:quality(80))
Prof. Sir John BellEllison Institute of Technology Oxford, UK
:quality(80))
Jimmy CreithField Applications Scientist, Bioinformatics, Oxford Nanopore Technologies
:quality(80))
Julie DragonUniversity of Vermont, USA
:quality(80))
Dr. Janessa LaskinBC Cancer Centre & University of British Columbia, Canada
:quality(80))
Joanne TrinhInstitute of Neurogenetics, University of Lübeck, Germany
:quality(80))
Prof. Joris VermeeschKU Leuven, Belgium
:quality(80))
Jose-Crispin Zavala AlvaradoPathoQuest, France
K
:quality(80))
Kimberley BillingsleyNational Institutes of Health, USA
:quality(80))
Kara DicksProgramme Manager, Conservation Genomics—ORG.ONE, Oxford Nanopore Technologies
:quality(80))
Dr. Karen SherwoodUniversity of British Columbia, Canada
:quality(80))
Katharina WolffTU Braunschweig, Germany
L
:quality(80))
Lyn ChittyGreat Ormond Street NHS Foundation Trust & UCL Great Ormond Street Institute of Child Health, UK
:quality(80))
Lauren LuiLawrence Berkeley National Laboratory, USA
:quality(80))
Dr. Luke W. MeredithWHO-EMRO World Health Emergencies, Egypt
:quality(80))
Dr. Luca MazzarellaEuropean Institute of Oncology, Italy
:quality(80))
Prof. Laurent MesnardSorbonne University, France
:quality(80))
Lorey SmithPeter MacCallum Cancer Centre, Australia
:quality(80))
Lara UrbanHemholtz AI, Germany
M
:quality(80))
Medini AnnavajhalaColumbia University Irving Medical Center, USA
:quality(80))
Mark AkesonUniversity of California, Santa Cruz, USA
:quality(80))
Prof. Matt BrownGenomics England, UK
:quality(80))
Morgan GueuningBlood Transfusion Service, Switzerland
Michael NakaiPeter MacCallum Cancer Centre, Australia
:quality(80))
Dr. Matt ParkerDirector, Clinical Bioinformatics Software, Oxford Nanopore Technologies
:quality(80))
Mile SikicGenome Institute of Singapore, A*STAR, Singapore
:quality(80))
Mrinalini WatsaSan Diego Zoo Wildlife Alliance, USA
N
:quality(80))
Natalia GarciaBioinformatics Workflow Developer, Oxford Nanopore Technologies
:quality(80))
Ndack NdiayePasteur Institute, Senegal
:quality(80))
Nick SeddonOptum Genomics, USA
P
:quality(80))
Paul ArvidsonGenomics England & SWAN, UK
:quality(80))
Ping LuPeking University, China
:quality(80))
Prof. Dr. Pieter WesselingPrincess Máxima Center for Pediatric Oncology & Amsterdam University Medical Centers, The Netherlands
R
:quality(80))
Dr. Rahul BatraGuy's and St Thomas' NHS Foundation Trust UK
:quality(80))
Rui ChenBaylor College of Medicine, USA
:quality(80))
Rea KobialkaInstitute of Animal Hygiene and Veterinary Public Health, Germany
:quality(80))
Rachel RubinsteinTechnical Product Manager, Software, Oxford Nanopore Technologies
:quality(80))
Rosemary Sinclair DokosSVP, Product and Programme Management, Oxford Nanopore Technologies
:quality(80))
Rhys WhiteInstitute of Environmental Science and Research, New Zealand
S
:quality(80))
Sergey BatalovRady Children’s Institute for Genomic Medicine, USA
:quality(80))
Seanne P. BuckwalterMayo Clinic, USA
:quality(80))
Sam DavisPrincipal Scientist, Machine Learning, Oxford Nanopore Technologies
:quality(80))
Sneha GoenkaStanford University & Princeton University, USA
:quality(80))
Sarah GriffithsBioinformatics Workflow Developer, Oxford Nanopore Technologies
:quality(80))
Sirisha HeskethClinical Bioinformatician, Oxford Nanopore Technologies
Sofia KudashevaEarlham Institute, UK
:quality(80))
Susie LeeTechnical Product Manager, Basecalling and Models, Oxford Nanopore Technologies
:quality(80))
Sean McKenzieAssociate Director, Genomic Applications Bioinformatics, Oxford Nanopore Technologies
:quality(80))
Dr. Simon PaineNottingham University Hospitals NHS Trust, UK
:quality(80))
Steph WilbrahamDirector, Automation Product Management, Oxford Nanopore Technologies
:quality(80))
Spike WillcocksChief Strategy Officer, Oxford Nanopore Technologies
T
:quality(80))
Thias Oberg BoesenNovo Nordisk A/S, Denmark
:quality(80))
Tomás Di DomenicoNational Cancer Research Center, Spain
:quality(80))
Tomasz DobrzyckiField Applications Scientist, New Product Introduction, Oxford Nanopore Technologies
:quality(80))
Dr. Telmo GraçaLonza, Switzerland
:quality(80))
Tina HanTwist Bioscience
:quality(80))
Dr. Thomas R. KreilTakeda, Austria
:quality(80))
Tetyana VasylyevaUniversity of California, Irvine, USA
:quality(80))
:quality(80))
:quality(80))
Oxford Nanopore Technologies
Sarah Griffiths
:quality(80))
- Job title
- Institution
- Bioinformatics Workflow Developer, Oxford Nanopore Technologies
- Biography
Sarah Griffiths is a Bioinformatics Workflow Developer in the Customer Workflows team at Oxford Nanopore Technologies. In her role, she creates Nextflow workflows as well as developing and maintaining existing workflows including wf-clone-validation, wf-transcriptomes, and wf-pore-c.
